Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001496 |
---|---|
Receipt number | R000001809 |
Scientific Title | A phase 1 study of the combination chemotherapy of sorafenib with cisplatin transcatheter arterial infusion for advanced hepatocellular carcinoma. |
Date of disclosure of the study information | 2008/12/02 |
Last modified on | 2014/01/21 19:57:27 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/11/11 00:52:41 | ||
2 | Update | 2008/11/11 01:01:10 | Email1 |
|
3 | Update | 2008/11/30 17:25:09 | Date of disclosure of the study information |
|
4 | Update | 2008/12/01 22:11:25 | Key inclusion criteria Key exclusion criteria |
|
5 | Update | 2008/12/01 22:20:04 | Key inclusion criteria |
|
6 | Update | 2008/12/01 22:33:47 | Organization Organization |
|
7 | Update | 2008/12/01 22:51:32 | Narrative objectives1 |
|
8 | Update | 2008/12/01 22:54:59 | Public title Acronym |
|
9 | Update | 2008/12/01 22:59:06 | Narrative objectives1 |
|
10 | Update | 2008/12/01 23:00:23 | Date of disclosure of the study information |
|
11 | Update | 2008/12/01 23:08:23 | Control |
|
12 | Update | 2009/01/05 07:04:13 | Recruitment status |
|
13 | Update | 2010/12/13 17:29:14 | Address Email1 |
|
14 | Update | 2010/12/13 17:30:22 | Recruitment status |
|
15 | Update | 2014/01/21 19:45:59 | Email Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
16 | Update | 2014/01/21 19:57:27 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results URL related to results and publications Results Results |